Diabetes Monitor - Information, education, and support for people with diabetes

Diabetes Monitor - Repaglinide (prandin)

Publication Date: 1/6/2010

repaglinide (Prandin) (Continued)

 

  • Start with low dose (0.5-2.0 mg/meal); increase weekly PRN (Maximum recommended dose is 4 mg/meal, 16 mg/day)

  • Approved for monotherapy or with metformin

  • May cause hypoglycemia

  • Weight gain possible

Previous slide Next slide Back to first slide View graphic version


Advertisement